Olivier Kosmider

12.7k total citations
107 papers, 2.5k citations indexed

About

Olivier Kosmider is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Olivier Kosmider has authored 107 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Hematology, 47 papers in Genetics and 37 papers in Molecular Biology. Recurrent topics in Olivier Kosmider's work include Acute Myeloid Leukemia Research (67 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers) and Chronic Lymphocytic Leukemia Research (19 papers). Olivier Kosmider is often cited by papers focused on Acute Myeloid Leukemia Research (67 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers) and Chronic Lymphocytic Leukemia Research (19 papers). Olivier Kosmider collaborates with scholars based in France, United States and Italy. Olivier Kosmider's co-authors include Michaëla Fontenay, Raphaël Itzykson, Pierre Fenaux, Éric Solary, François Dreyfus, Claude Preudhomme, Bruno Quesnel, Lionel Adès, Odile Beyne‐Rauzy and Véronique Gelsi‐Boyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Olivier Kosmider

96 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olivier Kosmider France	26	1.6k	1.2k	1.0k	294	236	107	2.5k
Manja Meggendorfer Germany	27	1.5k 1.0×	854 0.7×	949 0.9×	355 1.2×	292 1.2×	200	2.4k
Brenton G. Mar United States	16	1.5k 1.0×	982 0.8×	667 0.7×	350 1.2×	103 0.4×	33	2.3k
Eva Hellström‐Lindberg Sweden	20	1.5k 0.9×	855 0.7×	758 0.7×	156 0.5×	89 0.4×	29	1.9k
Martin Jädersten Sweden	22	1.7k 1.1×	857 0.7×	795 0.8×	205 0.7×	48 0.2×	63	2.1k
Éric Lippert France	23	1.3k 0.8×	968 0.8×	1.4k 1.4×	98 0.3×	603 2.6×	102	2.2k
Roberta La Starza Italy	24	976 0.6×	796 0.7×	370 0.4×	124 0.4×	239 1.0×	91	1.8k
Giovanna Rege‐Cambrin Italy	21	1.4k 0.9×	612 0.5×	893 0.9×	130 0.4×	352 1.5×	70	2.0k
Daniel B. Lipka Germany	23	878 0.6×	1.1k 0.9×	458 0.4×	304 1.0×	58 0.2×	60	1.9k
Lydia Roy France	22	1.4k 0.9×	551 0.5×	1.1k 1.1×	89 0.3×	719 3.0×	65	2.1k
Zuzana Zemanová Czechia	22	987 0.6×	744 0.6×	434 0.4×	235 0.8×	58 0.2×	139	1.7k

Countries citing papers authored by Olivier Kosmider

Since Specialization

Citations

This map shows the geographic impact of Olivier Kosmider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Kosmider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Kosmider more than expected).

Fields of papers citing papers by Olivier Kosmider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Kosmider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Kosmider. The network helps show where Olivier Kosmider may publish in the future.

Co-authorship network of co-authors of Olivier Kosmider

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Kosmider. A scholar is included among the top collaborators of Olivier Kosmider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Kosmider. Olivier Kosmider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Lin‐Pierre, Vincent Jachiet, Olivier Kosmider, et al.. (2025). Very long-term remission with azacitidine in VEXAS syndrome. Haematologica. 110(6). 1432–1435. 1 indexed citations

Bourguiba, R., Valentin Lacombe, David B. Beck, et al.. (2025). Characterizing VEXAS syndrome in women: Findings from an international multicenter study. Journal of Internal Medicine. 298(5). 516–524.

Cayuela, Jean‐Michel, Pierre Sujobert, Pascale Flandrin‐Gresta, et al.. (2025). Implementation science in hemato‐oncology molecular diagnostics in France via the Groupe des Biologistes Moléculaire des Hémopathies Malignes (GBMHM). HemaSphere. 9(4). e70121–e70121. 1 indexed citations

Jachiet, Vincent, Thibault Comont, Olivier Kosmider, et al.. (2025). [VEXAS Syndrome].. PubMed. 75(2). 196–200.

Rodrigues, François, Sara El Hoss, Emilie‐Fleur Gautier, et al.. (2024). Vexas Syndrome Is a New Cause of p53-Mediated Erythroblastopenia. Blood. 144(Supplement 1). 36–36. 4 indexed citations

Sujobert, Pierre, Olivier Kosmider, Damien Luque Paz, et al.. (2023). Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France. HemaSphere. 7(9). e943–e943. 2 indexed citations

Levavasseur, Françoise, Olivier Kosmider, Frédéric Pendino, et al.. (2023). FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells. Blood Advances. 7(13). 3265–3275. 14 indexed citations

Khider, Lina, Marie Templé, Cécile Bally, et al.. (2022). Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study. Journal of Thrombosis and Haemostasis. 20(11). 2697–2699. 13 indexed citations

Gandrillon, Olivier, Thibault Espinasse, Nicolas Garnier, et al.. (2021). Entropy as a measure of variability and stemness in single-cell transcriptomics. Current Opinion in Systems Biology. 27. 100348–100348. 17 indexed citations

10.

Mondésir, Johanna, David Sibon, Lise Willems, et al.. (2019). Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study. British Journal of Haematology. 187(1). 65–72. 1 indexed citations

11.

Koering, Catherine, Delphine Maucort‐Boulch, Guillaume Robert, et al.. (2016). An miRNA–DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia. Clinical Cancer Research. 23(12). 3025–3034. 29 indexed citations

12.

Patnaik, Mrinal M., Emnet A Wassie, Eric Padron, et al.. (2015). Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome. Blood Cancer Journal. 5(1). e270–e270. 46 indexed citations

13.

Humbrecht, Catherine, Katy Billot, Virginie Mariot, et al.. (2013). Epigenetic Control of NF-κB-Dependent FAS Gene Transcription during Progression of Myelodysplastic Syndromes. Molecular Cancer Research. 11(7). 724–735. 15 indexed citations

14.

Gay, Julie, Kévin Adam, Frédèrique Verdier, et al.. (2013). Tyrosine Kinase Inhibitors Induce Down-Regulation of c-Kit by Targeting the ATP Pocket. PLoS ONE. 8(4). e60961–e60961. 18 indexed citations

15.

Kosmider, Olivier, Éric Delabesse, Véronique Mansat‐De Mas, et al.. (2011). TET2 mutations in secondary acute myeloid leukemias: a French retrospective study. Haematologica. 96(7). 1059–1063. 31 indexed citations

16.

Itzykson, Raphaël, Olivier Kosmider, Thomas Cluzeau, et al.. (2011). Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias. Leukemia. 25(7). 1147–1152. 353 indexed citations

17.

Kosmider, Olivier, Raphaël Itzykson, Thomas Cluzeau, et al.. (2011). 306 Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias. Leukemia Research. 35. S120–S120. 4 indexed citations

18.

Nibourel, Olivier, Olivier Kosmider, Meyling Cheok, et al.. (2009). Association of TET2 Alterations with NPM1 Mutations and Prognostic Value in De Novo Acute Myeloid Leukemia (AML).. Blood. 114(22). 163–163. 6 indexed citations

19.

Kosmider, Olivier, Dorothée Selimoglu‐Buet, Isabelle Gallais, Nicole Denis, & Françoise Moreau-Gachelin. (2009). Erythropoietin Down-Regulates Stem Cell Factor Receptor (Kit) Expression in the Leukemic Proerythroblast: Role of Lyn Kinase. PLoS ONE. 4(5). e5721–e5721. 11 indexed citations

20.

Rimmelé, Pauline, Olivier Kosmider, Patrick Mayeux, Françoise Moreau-Gachelin, & Christel Guillouf. (2006). Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation. Blood. 109(7). 3007–3014. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact